Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Robert Rose who wrote (92765)	2/1/2000 9:03:00 PM
From: H James Morris	Read Replies (1) \| Respond to of 164684

Robert, Do you remember Sequenom (Sqnm) San Diego Co who Ipo'd today. A couple of weeks ago you told me you thought it was compelling but your concern was the underwriter. What did happen with Cra other than the super computer deal? >NEW YORK, Feb 1 (Reuters) - Industrial genomics company Sequenom Inc. <SQNM.O> burst on the scene Tuesday after its $26 a share initial public offering with a more than 200 percent gain, as investors rushed to buy the newest genomics issue. Biotech and genomic bioengineering stocks have been strong performers as the sector emerges as one of the ones to watch due to the recent breakthroughs in the human genomic mapping project and the new advances in science. San Diego-based Sequenom raised $130 million, with five million shares pricing at $26 each, above its upwardly, revised price range. The company had originally expected to raise $90 million. Warburg Dillon Read was the lead underwriter. Shares soared 54-1/2 toat 80-1/2 on the Nasdaq.